E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal Article
Abstract 2860: Does the Efficacy of the Low-Molecular Weight Heparin Enoxaparin over Unfractionated Heparin Balance the Safety Profile in ST-elevation Myocardial Infarction? A Meta-Analysis of 27,000 Patients
Sabina A. Murphy,C. Michael Gibson,David A. Morrow,Carolyn H. McCabe,Frans Van de Werf,Ian B. A. Menown,Frank Jiang,Elliott M. Antman +7 more
Journal ArticleDOI
Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
Nicholas Dietz,Nicholas Dietz,Christian T. Ruff,Christian T. Ruff,Robert P. Giugliano,Robert P. Giugliano,Michele Mercuri,Elliott M. Antman,Elliott M. Antman +8 more
TL;DR: Initial doses were higher than INR target doses in high-risk bleeding subpopulations as defined by the modified HAS-BLED and genotype sensitivity analysis when compared to established algorithms.
Journal ArticleDOI
Reply: Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration?
Journal ArticleDOI
Atrial Fibrillation - What Is It and How Is It Treated?
Book ChapterDOI
Myocardial Infarct Size Reduction
TL;DR: In 1912, Herrick concluded his classic article by presenting a logical approach to the treatment of myocardial infarction: “the hope for the damaged myocardium lies in the direction of securing a supply of blood through friendly neighbouring vessels so as to restore as far as possible its functional integrity”.